期刊文献+

牛蒡子苷元通过抑制PI3-K/Akt信号通路诱导肝癌细胞凋亡 被引量:13

Arctigenin, a Natural Lignan Compound, Induces Apoptotic Death of Hepatocellular Carcinoma Cells via Suppression of PI3-K/Akt Signaling
下载PDF
导出
摘要 目的探讨天然木脂素类化合物牛蒡子苷元对肝癌细胞生长的抑制作用及其可能机制。方法采用不同浓度的牛蒡子苷元处理Hep G2和Hep3B细胞,通过MTT法检测细胞增殖情况,流式细胞术检测细胞凋亡及细胞周期,免疫印迹检测细胞中caspase-9和caspase-3的活化情况以及抗凋亡蛋白的表达。进一步通过转染Akt质粒以及使用PI3K抑制剂,探讨牛蒡子苷元对肝癌细胞PI3K/Akt信号通路的影响。结果牛蒡子苷元能以浓度依赖性方式显著抑制肝癌细胞增殖并促进其凋亡,同时抑制肝癌细胞中PI3K/Akt信号通路活化,降低抗凋亡蛋白Bcl-x L、Mcl-1和survivin的表达,抑制m TOR和S6K的磷酸化;细胞过表达Akt活化蛋白后可抑制牛蒡子苷元的上述效应,而PI3K抑制剂联合作用可增强上述效应。结论牛蒡子苷元可通过抑制PI3K/Akt信号通路下调抗凋亡蛋白的表达进而促进肝癌细胞凋亡。 Objective To explore the effects of arctigenin, a natural lignan compound, on the growth of human hepatocellular carcinoma (HCC) cells and the possible mechanisms. Methods The HepG2 and Hep3B cells were treated with different concentrations of arctigenin. The MTF assay was applied to detect the cell proliferation of HCC cells. Flow cytometry was applied to detect the cell apoptosis and cell cy- cle, and Western blot was adopted to detect the expressions of caspase-3 and caspase-9 as well as the expressions of anti-apoptotic proteins in cells. Manipulating Akt signaling was used to determine its role in the action of aretigenin. Results Arctigenin significantly inhibited the proliferation and induce the apoptosis of HCC cells in a concentration-dependent manner. Arctigenin induced the activation of caspase-9 and caspase-3. Overexpression of a constitutively active Akt mutant blocked arctigenin-induced apoptosis. Comhinational treatment with arctigenin and the PI3K inhibitor LY294002 enhanced apoptosis significantly. Arctigenin reduced the expression of Bcl-xL, Mcl-I and sur- viving, and the phosphorylation of roTOR and S6K, which were significantly reversed by overexpression of constitutively-active Akt. Con- clusion Arctigenin could down-regulate the expressions of anti-apoptotic proteins and promote the apoptosis of hepatocellular carcinoma ceils by inactivating PI3-K/Akt signaling.
出处 《肿瘤药学》 CAS 2015年第6期430-435,共6页 Anti-Tumor Pharmacy
基金 湖南省自然基金资助项目(14JJ2092)
关键词 牛蒡子苷元 原发性肝癌 细胞凋亡 Arctigenin Hepatocellular carcinoma Apoptosis
  • 相关文献

参考文献26

  • 1Vibert E,Ishizawa T.Hepatocellular carcinoma:Western and Eastern surgeons' points of view[J].J Vise Surg,2012,149(5):e302-e306.doi:10.1016/j.jviscsurg.2012.05.OOL.
  • 2Graf D,VallbShmer D,Knoefel WT,et al.Multimodal treat- ment of hepatocellular carcinoma[J].Eur J Intern Med,2014,25(5):430-437.doi:10.1016/j.ejim.2014.03.001.
  • 3Cao H,Phan H,Yang LX.Improved chemotherapy for he- patocellular carcinoma[J].Anticancer Res,2012,32(4):1379-1386.
  • 4Hennessy BT,Smith DL,Ram PT,et al.Exploiting the PI3K/AKT pathway for cancer drug discovery[J].Nat Rev Drug Discov,2005,4(12):988-1004.doi:10.1038/nrdl902.
  • 5Sarbassov DD,Guertin DA,Ali SM,et al.Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex[J]. Science,2005,307(5712):1098-1101.doi:10.1126/sci- ence.1106148.
  • 6Franke TF,Kaplan DR,Cantley LC,et al.Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate[J].Science,1997,275(5300):665-668.
  • 7Toker A,Yoeli-Lerner M.Akt signaling and cancer:sur- viving but not moving on[J].Cancer Res,2006,66(8):3963-3966.doi:10.1158/0008-5472.CAN-06-0743.
  • 8Hou e d e N,Pourquier P.Targeting the genetic altera- tions of the PI3 K-AKT-mTOR pathway:its potential use in the treatment of bladder cancers[J].Pharmacol Ther,2015,145:1-18.doi:10.1016/j.pharmthera.2014.06.004.
  • 9Holz MK,Blenis J.Identification of S6 kinase I as a novel mam- malian target of rapamycin(mTOR)-phosphorylating kinase[J]. J Biol Chem,2005,280(28):26089-26093.doi:10.1074/jbc. M504045200.
  • 10Psyrri A,Arkadopoulos N,Vassilakopoulou M,et al.Path- ways and targets in hepatocellular carcinoma[J].Expert Rev Anticancer Ther,2012,12(10):1347-1357.doi:10.1586/era.12.113.

同被引文献124

引证文献13

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部